Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Clasificación en acciones #29675
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Precio por acción
$0.20877985
Capitalización bursátil
$20.11M
Cambio (1 día)
-3.03%
Cambio (1 año)
-66.13%
País
JP
Comercio Modalis Therapeutics Corporation (4883)

Categoría

Historial de desdoblamientos de acciones de Modalis Therapeutics Corporation (4883)
La acción Modalis Therapeutics Corporation (símbolo: 4883) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 19, 2026.
Una acción 4883 comprada antes de Aug 19, 2026 equivaldría hoy a 0 acciones 4883.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR